Reported September 20, 2026: 'Australia's Telix Pharma Agrees To Buy Germany's ITM Isotope For About $1.65B'

Telix Pharmaceuticals Says First Patients In US Dosed With Pixclara, FDA-Approved, Amino Acid Positron Emission Tomography Drug For Glioma Imaging

First doses of Pixclara administered in Cleveland (OH) and Indianapolis (IN) marking the start of U.S. commercial availability.Pixclara is the only FDA-approved radiopharmaceutical imaging drug for glioma (brain

Telix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy

HC Wainwright & Co. Reiterates Buy on Telix Pharmaceuticals, Maintains $20 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Buy and maintains $20 price target.

Wedbush Reiterates Outperform on Telix Pharmaceuticals, Maintains $22 Price Target

Wedbush analyst David Nierengarten reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Outperform and maintains $22 price target.